FDA Solicitation Of Industry Input Prior To Draft Guidances Urged By PhRMA
This article was originally published in The Tan Sheet
Executive Summary
FDA should seek counsel from drug manufacturers before issuing draft guidances, the Pharmaceutical Research & Manufacturers of America suggests in recent comments to the agency on the implementation of Good Guidance Practice provisions included in the FDA Modernization Act.